Skip to Content

M159 M159 (Didanosine Delayed Release 125 mg)

Pill with imprint M159 M159 is White, Capsule-shape and has been identified as Didanosine Delayed Release 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M159 M159

Didanosine delayed release 125 mg M159 M159

Didanosine Delayed Release

Imprint
M159 M159
Strength
125 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8886
Inactive Ingredients
ferrosoferric oxide, carboxymethylcellulose sodium, silicon dioxide, diethyl phthalate, gelatin, hypromelloses, methacrylic acid - methyl methacrylate copolymer (1:1), propylene glycol, shellac, trisodium citrate dihydrate, sodium lauryl sulfate, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, potassium hydroxide, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M159 M159"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.